In December 2011, the Food and Drug Administration (FDA) recommended that health care providers not alter their current practice for treating depression in pregnant patients. The recommendation was based on a review of data that up to that point had been inconsistent on whether using antidepressants known as selective serotonin reuptake inhibitors (SSRIs) could cause harm to developing fetuses if taken by the mother during pregnancy. However, a month after the FDA’s announcement that studies had not established a link between use during pregnancy and birth defects, a large retrospective cohort study was published that strongly suggests that SSRI exposure ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.